Methamphetamine Treatment in Reading, PA

Methamphetamine is not the headline drug in Berks County — fentanyl is — but the coroner's records show it in dozens of local deaths each year, and most of the time it is not alone. Because meth has no medication behind it, the help that works is behavioral, and it takes a program willing to run it. Here is what the local numbers show and how to start.

What is the safest way to start methamphetamine treatment in Reading?

It depends on the person's state right now. If someone is paranoid, hallucinating, or a danger to themselves or others, that is a 911 situation — meth-induced psychosis is a medical emergency, not something to talk through. If they are stable but using regularly, the strongest evidence is a structured outpatient program built on contingency management and cognitive behavioral therapy, since no medication exists. If they have just stopped and are crashing, the risk is depression and relapse rather than physical danger — a same-week assessment beats going it alone.

Methamphetamine in Berks County's data

The Berks County Coroner's Office 2024 annual report recorded 29 methamphetamine-related deaths, a 17% decrease from the 35 recorded in 2023. The finding that should shape how anyone here thinks about meth is this: those deaths occurred in combination with fentanyl 59% of the time. Meth in Berks County is frequently a co-involved drug, and the fentanyl that travels with it is the more immediate threat to life.

Countywide, accidental overdose deaths were 117 in 2023, down from a record 137 in 2022, and fell another 23% in 2024. Statewide, the Pennsylvania Department of Health counted 3,341 overdose deaths in 2024, a 29.2% drop from 2023, and reported that 41% involved opioids and stimulants together. Nationally, CDC's SUDORS analysis found that among overdose deaths from January 2021 through June 2024, 31.2% involved methamphetamine, and about 69% of methamphetamine-involved deaths also involved opioids.

Berks County holds an estimated 439,000 people, roughly 96,000 of them in Reading, per Census Bureau estimates.

No FDA-approved medication — and why that is not the end

NIDA describes methamphetamine as a lab-made stimulant with high addiction potential whose short-term effects can include paranoia, anxiety, rapid or irregular heartbeat, and stroke, and it states that there is no FDA-approved medication for methamphetamine use disorder or any other stimulant use disorder. Hearing that, some people assume there is nothing clinical to do. The evidence argues otherwise, and SAMHSA's January 2025 advisory treats these as the primary interventions precisely because no pill exists:

• Contingency management (CM) — a voucher or prize earned for a drug test showing no recent use; the most strongly supported treatment for stimulant use.
• Cognitive behavioral therapy (CBT) — identifying the cues and situations that drive use, and building a plan for them.
• The Matrix Model — a structured 16-week outpatient program designed for stimulant use, blending individual and group sessions, family education, and drug testing.
• Motivational interviewing — working with the part of you that is still unsure about stopping.

Without a daily medication carrying part of the load, showing up is the treatment. Ask any program: Do you offer contingency management for stimulants? Voucher or prize? How soon can I start?

Withdrawal: not usually dangerous, but not easy

Meth withdrawal is generally not medically dangerous the way alcohol or benzodiazepine withdrawal can be. NIDA describes depression, anxiety, irritability, broken sleep, and cravings that peak in the first days and can persist in milder form for weeks. Two risks deserve respect: the post-use depression, which has been linked to suicide risk — call or text 988 if that describes you or someone you love — and meth-induced psychosis, where paranoia and hallucinations may require 911.

Because the danger is delayed rather than immediate, people often self-manage withdrawal and relapse within days. An assessment first — even a same-week outpatient appointment — beats doing it alone.

Treatment options around Reading

FindTreatment.gov data accessed October 2026 list 7 substance use treatment facilities within 5 miles of Reading and 22 within 25 miles, spanning outpatient, intensive outpatient, and residential care. The locator does not indicate which programs run contingency management, so ask by phone; counts change as programs open and close.

Local entry points:

• Berks TASC — the licensed central intake agency (19 N. 6th Street, Reading; 610-375-4426, weekdays 8 a.m. to 4 p.m.); assesses county residents and refers them into care
• Reading Hospital 24/7 Drug and Alcohol Hotline — 484-628-4673
• Council on Chemical Abuse (COCA) — 610-376-8669, the county's substance use resource hub

Paying for treatment

Pennsylvania Medical Assistance covers medically necessary substance use disorder treatment, including intensive outpatient care. Berks TASC's central intake arranges publicly funded care for county residents who lack coverage. The SAMHSA National Helpline, 1-800-662-4357, is free and confidential anywhere in the country.

How to start today

1. If someone is a danger to themselves or others, or unresponsive or breathing slowly, call 911. For a mental health or substance use crisis, call or text 988.
2. Call or text (800) 653-9376 to talk through behavioral treatment options with a specialist, or use this form:

Calling is free; the referral service is paid for by treatment providers, and we check your benefits before you commit.

3. Search findtreatment.gov with a Reading ZIP code and ask each program about contingency management for stimulant use.
4. Call Berks TASC at 610-375-4426 on a weekday for an assessment, and pick up naloxone from COCA or SOS Berks — most meth deaths in Berks County also involve fentanyl.

Meth recovery is built from structure and repetition rather than a prescription, and it is happening in Berks County every week. Starting is a single call.

This page is general health information, not medical advice. It is not affiliated with or endorsed by any facility named above.

Frequently asked questions